Inhibrx Biosciences, Inc. INBX Business Segments — Contract manufacturing
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept inbx:ResearchAndDevelopmentExpenseContractManufacturing.
The official record: Inhibrx Biosciences, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s business segments — contract manufacturing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s business segments — contract manufacturing?
- Inhibrx Biosciences, Inc. (INBX) reported business segments — contract manufacturing of $4.9M in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s business segments — contract manufacturing changed year-over-year?
- Inhibrx Biosciences, Inc.'s business segments — contract manufacturing decreased by 64.8% year-over-year, from $13.91M to $4.9M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s business segments — contract manufacturing?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s business segments — contract manufacturing has grown at a -49.6% compound annual growth rate (CAGR), from $77.25M to $19.59M.
- What does business segments — contract manufacturing mean?
- Reflects the expenses paid to third-party organizations for the manufacturing and production of biologic therapeutic candidates. This metric highlights the company's reliance on external manufacturing partners to scale production for clinical or commercial needs.